Synvivia

2341 Grant Street

Berkeley

Established 2016

Owner and operator of a biotechnology company intended to focus on developing engineered organisms that safely and effectively treat diseases. The company’s genetically engineered organisms are controlled by small molecules over protein function and by generating biosensors that identify and improve new enzymatic activities, enabling healthcare providers to diagnose the disease easily and give proper treatment to the patients.